Parameter | WOMEN-WS | WOMEN-CONTROL | WS/CONTROL (p –ANOVA/Kruskal-Wallisa) | |||||
---|---|---|---|---|---|---|---|---|
Study 1 | Study 2 | (p) | Study 1 | Study 2 | (p) | Study 1 | Study 2 | |
TC (mmol/L) | 4.98 ± 0.65 | 4.64 ± 0.89 | 0.318 | 4.94 ± 1.04 | 4.81 ± 1.11 | 0.583 | 0.252 | 0.562 |
TG (mmol/L) | 0.98 ± 0.51 | 0.84 ± 0.28 | 0.612 | 1.33 ± 0.89 | 1.19 ± 0.85 | 0.883 | 0.885 | 0.579 |
HDL (mmol/L) | 1.99 ± 0.42 | 1.91 ± 0.52 | 0.658 | 1.41 ± 0.30 | 1.52 ± 0.30 | 0.603 | 0.519 | 0.518 |
LDL (mmol/L) | 3.13 ± 0.55 | 2.82 ± 0.69 | 0.359 | 3.42 ± 1.03 | 3.31 ± 1.08 | 0.765 | 0.152 | 0.469 |
Asprosin (ng/mL) | 47.83 ± 94.05 | 34.94 ± 74.82 | 0.753 | 72.71 ± 102.03 | 89.16 ± 126.48 | 0.987 | 0.315 | 0.185 |
Adiponectin (µg/mL) | 1.19 ± 1.20 | 2.90 ± 0.68 | 0.000* | 1.33 ± 0.62 | 1.08 ± 0.61 | 0.431 | 0.002* | 0.051* |
Resistin (ng/mL) | 1.25 ± 0.51 | 1.83 ± 0.38 | 0.000* | 1.15 ± 0.38 | 1.08 ± 0.28 | 0.874 | 0.003* | 0.450 |
Leptin (ng/mL) | 0.76 ± 0.24 | 1.12 ± 0.31 | 0.013* | 0.60 ± 0.27 | 0.53 ± 0.18 | 0.896 | 0.000* | 0.339 |